Anastomotic Leakage in Colorectal Cancer Surgery in Syria
NCT ID: NCT07092631
Last Updated: 2026-01-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
119 participants
OBSERVATIONAL
2016-01-04
2025-10-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Anastomotic Leak in Covid-19
NCT06663033
Anastomotic Leakage After Colorectal Surgery.
NCT07144683
Anastomotic Leakage in Right Colectomy
NCT06553261
Anastomotic Leakage After Anterior Resection of Rectal Cancer
NCT03281070
Role of Indexed Oxygen Delivery in Anastomotic Insufficiencies in Elective Laparoscopic Colorectal Resections for Cancer
NCT07099820
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This retrospective cohort study was conducted at the Department of General Surgery, Damascus Hospital, Syria, to identify risk factors associated with AL after elective sigmoid colon and rectal resections for colorectal adenocarcinoma and to evaluate outcomes following the implementation of revised institutional guidelines. The study comprised two sequential cohorts. The first cohort included patients operated on between January 2016 and March 2024 and served to identify patient and procedure related risk factors for AL. Findings from this initial analysis prompted revisions to local preoperative preparation and perioperative management protocols, with particular emphasis on nutritional optimization, correction of hypoalbuminemia, cautious use of perioperative blood transfusion, and intensified postoperative monitoring for high-risk patients.
A follow-up cohort was subsequently analyzed, including patients treated between April 2024 and October 2025 after implementation of the updated guidelines. Outcomes in this cohort were compared with those of the initial cohort to assess the clinical impact of the protocol changes. The primary outcome was the occurrence of anastomotic leakage, defined according to the International Study Group of Rectal Cancer (ISREC) criteria. Secondary outcomes included postoperative complications, perioperative blood transfusion, intensive care unit admission, and postoperative mortality.
All included patients underwent elective resection of the sigmoid colon or rectum for histologically confirmed colorectal adenocarcinoma. Emergency cases, non-neoplastic indications, and incomplete records were excluded. Surgical procedures were classified according to operative approach, anastomotic technique, anastomotic location, and use of diverting ileostomy. Data were retrospectively extracted from medical records and operative notes and verified through structured follow-up when available.
By comparing outcomes before and after guideline implementation, this study aims to demonstrate how locally driven, evidence-based modifications to perioperative care can reduce anastomotic leakage and improve surgical outcomes, even in settings constrained by prolonged conflict and limited resources.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
The First Cohort
Pre-guideline cohort - patients treated before the implementation of the updated hospital guidelines (January 2016 - March 2024).
No interventions assigned to this group
The follow-up cohort
Post-guideline cohort - patients treated after the implementation of the updated guidelines (April 2024 - October 2025).
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Non-tumor related colorectal surgeries
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Syrian Private University
OTHER
Damascus Hospital
OTHER
Elie Bitar
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elie Bitar
Elie Wadie Bitar MD, Faculty of Medicine, Syrian Private University, Damascus, Syria.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Syrian Private University
Damascus, , Syria
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan: Anastomotic Leakage in Syria- first cohort
Document Type: Study Protocol: Follow-Up Cohort on Anastomotic Leakage
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB number 1497/436
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.